Founded in 1984 in Parma to offer a maintenance and assistance service to the food industry, over time – and more precisely in 1998 – Idroinox Impianti has expanded its core business to other strategic market segments such as the pharmaceutical sector, the one in which it is most active today. Thanks to the experience gained in over 35 years of activity, this all-Italian excellence has focused its core business on the production process of the pharmaceutical industry, working on projects for major national and international companies in the sector. Paolo Giacopinelli, CEO of Idroinox Impianti, tells us about the goals of a company that looks to the future with optimism.
by Roberta Imbimbo
Dr. Giacopinelli, with what mission was Idroinox Impianti born? Tell us a little about your story.
It was 29 February 1984 when, together with five other courageous and passionate entrepreneurs from Parma, I set up a small family business operating mainly in the food market. Over time, however, also following a reorganisation of governance (in 2010 the partners became two, President Nicola Marchese and myself), the company expanded its core business to other strategic activities, strongly entering the pharmaceutical market, a sector that still represents 90% of its turnover. Today, Idroinox Impianti is a company that is highly specialised in the design and development of production systems necessary for the production of pharmaceuticals, according to exclusively scientific dictates, such as particular mixtures necessary for the production of drugs or medical products of high technical and qualitative value. Thanks to the experience and know-how acquired over many years of activity, and nevertheless thanks to a highly qualified team, the company has been able to grow considerably both in terms of geographical expansion – today it boasts hundreds of active customers in Italy and abroad – and in size – today it employs around forty people – and in terms of turnover, which has reached around 7 million euros per year.
What kind of market is it in which you operate? What peculiarities distinguish you from your competitors?
In a market that is becoming increasingly competitive every year, characterised by the presence of other well-structured players, Idroinox Impianti has managed to differentiate itself and assert its leadership thanks to the quality, reliability, and professionalism demonstrated over the years, and thanks to the considerable investments made in technology, research, and training; decisive investments that have allowed it to stay at the forefront of a constantly evolving market, thus proactively meeting the needs of each customer, mostly large multinationals in the pharmaceutical sector. Recently, we have invested heavily in the latest technologies and ad hoc research processes: during the pandemic, for example, we focused on the treatment of Covid-19, working closely with Pfizer. Another of our distinguishing features is our ability to have innovated production and organisational processes in a sustainable way, thus becoming active players in the new green revolution. With our ethical values, every day our brand pays tribute to a corporate culture that is increasingly oriented towards respect, integrity and innovation, with an eye on social, environmental and economic sustainability.
So many achievements have been made in all these years. Future goals?
In a market that offers great growth prospects, our priority objective is to safeguard the efficiency and reliability of our production processes, to always guarantee high quality products, working at the highest level. Quality is an essential requirement for us, and it is the impetus that has driven us to pay close attention to control protocols and to work hard to bring the best that the market can demand. The impact of this vision has proved powerful, and has enabled us to become in a short time one of the most important companies in Italy for hundreds of customers who have placed their trust in our work. And whom I thank today because it is also thanks to them that we have achieved these extraordinary results. Despite our achievements to date, however, the company will continue to develop process innovations and new technologies for the treatment of particular pathologies (we will soon file a patent for dialysis systems).
For more info (https://www.idroinox.com)
